China Pharma Inc. (CPHI)

AMEX: CPHI · Real-Time Price · USD

1.99

-0.16 (-7.44%)

At close: May 01, 2025, 3:58 PM

1.97

-0.95%

After-hours: May 01, 2025, 07:45 PM EDT

China Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	4,528.9B	7.01M	8.1M	9.64M	10.87M	10.92M	12.33M	13.21M	15.57M
Cost of Revenue	6,514.6B	7.29M	8.6M	9.29M	8.91M	9.44M	10.36M	10.74M	12.35M
Gross Profit	-1,985.6B	-281.08K	-493.92K	349.27K	1.95M	1.48M	1.97M	2.47M	3.22M
Operating Income	-4,588.9B	-2.75M	-3.55M	-3.12M	-2.46M	-3.39M	-3.97M	-4.5M	-4.19M
Interest Income	6.64K	6.6K	10.76K	3.04K	5.67K	27.53K	38.52K	64.41K	130.57K
Pretax Income	-4,736.4B	-3.08M	-3.97M	-3.4M	-2.87M	-20.7M	-10.86M	-19.15M	-8.87M
Net Income	-4.74M	-3.08M	-10.22M	-3.94M	-3.16M	-21.02M	-10.75M	-19.28M	-9.18M
Selling & General & Admin	2,313.6B	2.25M	2.87M	3.15M	4.04M	4.64M	5.77M	6.87M	7.39M
Research & Development	283.94K	240.08K	185.86K	318.96K	377.96K	229.64K	172.38K	90.47K	365.97K
Other Expenses	289.64B	-15.76K	93.85K	n/a	115.19B	7,576.5B	n/a	4,833.8B	n/a
Operating Expenses	2,603.2B	2.47M	3.15M	3.46M	4.42M	4.87M	-12.42M	-21.15M	-11.37M
Interest Expense	154.14K	333.6K	434.62K	542K	294.16K	321.72K	451.26K	539.33K	849.56K
Selling & Marketing Expenses	528.82B	780.33K	1.07M	1.5M	2.22M	2.35M	3.22M	3.46M	4.04M
Cost & Expenses	9,117.8B	9.76M	5.54M	12.76M	13.33M	14.31M	-2.07M	-10.4M	978.03K
Income Tax Expense	n/a	n/a	6.25M	542K	294.16K	321.72K	109.99K	122.63K	308.18K
Shares Outstanding (Basic)	17.46M	3.38M	5.26M	4.61M	4.61M	4.61M	4.61M	4.61M	4.61M
Shares Outstanding (Diluted)	17.46M	3.38M	5.26M	4.61M	4.61M	4.61M	4.61M	4.61M	4.61M
EPS (Basic)	-0.27	-0.91	-1.94	-0.85	-0.72	-4.82	-2.47	-4.42	-2.11
EPS (Diluted)	-0.27	-0.91	-1.94	-0.85	-0.72	-4.82	-2.47	-4.42	-2.11
EBITDA	-4,588.9B	8.44K	-837.69K	230.34K	106.85K	-17.45M	-7.15M	-15.32M	-4.95M
EBIT	-4,890.5B	-2.75M	-3.54M	-2.86M	-2.57M	-20.38M	-10.41M	-18.62M	-8.02M
Depreciation & Amortization	2.62M	2.75M	2.7M	3.09M	2.68M	2.93M	3.26M	3.29M	3.08M